CXCL9 and autoimmune pancreatitis: To answer this question, we determined the effect of blocking CXCL9/CXCL10-CXCR3 interaction on development of AIP by administration of a neutralizing antibody (Ab) against CXCR3 or control Ab at the time of each poly(I:C) injection.